LeMaitre Vascular, Inc. (LMAT)
99.52
-1.91
(-1.88%)
USD |
NASDAQ |
May 21, 16:00
99.60
+0.08
(+0.08%)
After-Hours: 19:59
LeMaitre Vascular Research and Development Expense (TTM) : 14.10M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Globus Medical, Inc. | 150.48M |
| GE Healthcare Technologies, Inc. | 1.262B |
| Alphatec Holdings, Inc. | 76.80M |
| Apyx Medical Corp. | 3.334M |
| Integer Holdings Corp. | 51.39M |